Spironolactone Tablet
Product Images NDC 71335-0966

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 71335-0966). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl713350966)

Label for Spironolactone 100 mg tablet, an oral prescription drug packaged by Bryant Ranch Prepack in Burbank, CA. The label includes a comparison reference to Aldactone 100 mg tablet by Amneal Pharmaceuticals Pvt. Ltd. It also provides storage instructions (20°-25°C) and safety advice to keep drugs out of reach of children.*

FDA Label Image

20 (Spironolactone Tablets Usp 1)

Chemical structure of Spironolactone, showing its molecular framework with functional groups including keto and thioacetate moieties.*

FDA Label Image

10 (Spironolactone Tablets Usp 2)

A Kaplan-Meier survival curve comparing probability over months between Spironolactone and placebo groups. The graph shows two lines, with the Spironolactone group represented by a dashed line and the placebo group by a solid line, indicating higher survival probability for Spironolactone. The x-axis denotes time in months, and the y-axis shows probability. Statistical significance is noted with a log-rank p-value less than 0.001.*

FDA Label Image

10 (Spironolactone Tablets Usp 3)

A forest plot chart showing subgroup analyses comparing Spironolactone and placebo across various patient characteristics—age groups, sex, race, left ventricular ejection fraction (LVEF) percentages, heart failure types, NYHA class, diabetes status, serum creatinine levels, creatinine clearance, potassium levels, digoxin use, ACE inhibitor use, and beta blocker use. The plot presents hazard ratios (HR) with 95% confidence intervals, number of patients (N), and percentage distribution, indicating relative treatment effects.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.